Skip to main content

Lecture 10: Case Study: First-in-Human Formulations for Poorly Soluble APIs

Want a FREE preview of this lecture? Click Here

Upon completion of this lecture of the eCourse, the participant should be able to:
  • Review current strategies for first in man dosing.
  • Compare and contrast the advantages and disadvantages using different formulation strategies.
  • Analyze different examples for first in man formulations.